W002 Hands-on: Scar Revision
DESCRIPTION
This session is tailored to advanced dermatologic surgeons. It offers small group, hands-on experience practicing a variety of surgical scar revision techniques, with faculty engaged in teaching at each table. Z-plasty, geometric broken line closure, and W-plasty will be discussed and performed. Design and execution for repair of ectropion, eclabion, alar notching, melolabial fold distortion, vermillion border distortion, brow distortion and tenting/webbing will be performed. Participants will have the opportunity for realistic hands-on practice with cadaveric arms and heads.
LEARNING OBJECTIVES
Recognize when a z-plasty, geometric broken line closure, or w-plasty can be utilized to improve scar outcome.
Design and execute repair of: ectropion, eclabion, alar notching, melolabial fold distortion, vermillion border distortion, brow distortion, and tenting/webbing.
Implement peri-procedural assessment and strategies for avoidance and management of complications.
SCHEDULE
9:00 AM
Introduction
Ramona Behshad, MD, FAAD
9:05 AM
Scar Assessment and Scar Disruption Techniques
9:15 AM
Hands-on time
9:30 AM
Z-plasty
Ramona Behshad, MD, FAAD
9:40 AM
Hand on time
10:00 AM
Preventing and Managing Ectropion: What the Dermatologist Needs to Know
Sonul Mehta, MD
10:20 AM
Hand-on time
10:45 AM
Restoring the Melolabial Fold
Jerry D. Brewer, MD, MS, FAAD
10:55 AM
Hands-on time
11:10 AM
Nasal Scars: When is Surgery Appropriate
Stacy McMurray, MD, FAAD
11:40 AM
Scar cases
11:50 AM
Q and A
DIRECTOR
Ramona Behshad, MD, FAAD
Saint Louis University
SPEAKERS
Jerry D. Brewer, MD, MS, FAAD
Stacy McMurray, MD, FAAD
Vanderbilt University Medical Center
Sonul Mehta, MD
Hospital of the University of Pennsylvania/Penn Medicine
DISCLOSURES
Ramona Behshad, MD, FAAD
Castle Biosciences, Inc – Investigator(Grants/Research Funding);
Jerry D. Brewer, MD, MS, FAAD
No financial relationships exist with ineligible companies.
Stacy McMurray, MD, FAAD
No financial relationships exist with ineligible companies.
Sonul Mehta, MD
No financial relationships exist with ineligible companies.